Elaia
Elaia is a Paris-based venture capital firm established in 2002, managing over €700m. It specializes in early-stage investments, focusing on disruptive startups in the digital economy, deep tech, and software technology sectors across Europe and Israel. With a team boasting over 75 years of combined experience in venture capital and digital industries, Elaia provides close, proactive support to its entrepreneurs, aiming to help them grow into global leaders.
Top Stages
Past deals in Simulation
Zymvol Biomodeling
Seed Round in 2025
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Zymvol Biomodeling
Seed Round in 2023
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Sim&Cure
Series A in 2019
Sim&Cure, SA is a software development company based in Grabels, France, established in 2014. The company specializes in creating innovative simulation models for planning endovascular and aneurysm treatments, focusing on optimizing medical devices. Sim&Cure offers a range of products, including Sim&Size, which helps clinicians determine the optimal size of cerebral medical devices tailored to individual patients' anatomies. Additionally, the company provides StentDeviceSizing (STsize), a module that simulates the deployment of laser-cut stents, and FlowDiverterSize (FDsize), which assists in identifying the correct position and size for treating cerebral aneurysms. Sim&Cure is notable for being the first company cleared to market a patient-based simulation model that predicts the deployment of various medical devices, enhancing the ability of neurologists to effectively treat neurovascular disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.